MDA Space Ltd.
MDALF
$16.45
-$0.3051-1.82%
| Weiss Ratings | MDALF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Reward Grade | B+ | |||
| Rating Factors | MDALF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Excellent | |||
| Efficiency Index | Good | |||
| Solvency Index | Good | |||
| Total Return Index | Good | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | MDALF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.66 | |||
| Price History | MDALF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -13.04% | |||
| 30-Day Total Return | -3.15% | |||
| 60-Day Total Return | -15.77% | |||
| 90-Day Total Return | -17.67% | |||
| Year to Date Total Return | -17.41% | |||
| 1-Year Total Return | 53.69% | |||
| 2-Year Total Return | 225.68% | |||
| 3-Year Total Return | 101.03% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -23.93% | |||
| 52-Week Low % Change | 97.29% | |||
| Price | MDALF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $22.02 | |||
| 52-Week Low Price | $8.49 | |||
| 52-Week Low Price (Date) | Jun 03, 2024 | |||
| 52-Week High Price (Date) | Dec 05, 2024 | |||
| Valuation | MDALF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 2.05B | |||
| Enterprise Value | 2.03B | |||
| Price/Earnings (TTM) | 36.62 | |||
| Earnings Per Share (TTM) | 0.46 | |||
| Earnings Per Share Growth | 55.21% | |||
| Price/Earnings To Growth | 0.66 | |||
| Price/Sales (TTM) | 2.84 | |||
| Price/Book (Q) | 2.49 | |||
| Enterprise Value/Revenue (TTM) | 2.58 | |||
| Price | $16.45 | |||
| Enterprise Value/EBITDA (TTM) | 16.44 | |||
| Enterprise Value/EBIT | 25.70 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | MDALF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 133.36M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | MDALF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 905 790 2800 | |||
| Address | 7500 Financial Drive Brampton, ON L6Y 6K7 | |||
| Website | mda.space | |||
| Country | Canada | |||
| Year Founded | 1969 | |||
| Profitability | MDALF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 10.02% | |||
| Profit Margin | 7.35% | |||
| Management Effectiveness | MDALF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 2.86% | |||
| Return on Equity | 7.12% | |||
| Income Statement | MDALF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 786.60M | |||
| Total Revenue (TTM) | 786.60M | |||
| Revenue Per Share | $5.90 | |||
| Gross Profit (TTM) | 237.27M | |||
| EBITDA (TTM) | 123.27M | |||
| EBIT (TTM) | 78.88M | |||
| Net Income (TTM) | 57.83M | |||
| Net Income Avl. to Common (TTM) | 57.83M | |||
| Total Revenue Growth (Q YOY) | 64.32% | |||
| Earnings Growth (Q YOY) | 80.70% | |||
| EPS Diluted (TTM) | 0.46 | |||
| EPS Diluted Growth (Q YOY) | 65.64% | |||
| Balance Sheet | MDALF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 115.86M | |||
| Cash Per Share (Q) | $0.87 | |||
| Total Current Assets (Q) | 435.42M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 817.33M | |||
| Current Ratio (Q) | 0.574 | |||
| Book Value Per Share (Q) | $6.73 | |||
| Total Assets (Q) | 1.81B | |||
| Total Current Liabilities (Q) | 758.25M | |||
| Total Debt (Q) | 95.08M | |||
| Total Liabilities (Q) | 987.95M | |||
| Total Common Equity (Q) | 817.33M | |||
| Cash Flow | MDALF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -167.51M | |||
| Cash from Financing (TTM) | -313.92M | |||
| Net Change in Cash (TTM) | 105.22M | |||
| Levered Free Cash Flow (TTM) | 463.98M | |||
| Cash from Operations (TTM) | 590.63M | |||
